|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Expert Opin Drug Saf. 3(3):231-48 |
Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting. |
Herrstedt J.
Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. jrhe@herlevhosp.kbhamt.dk |
Publication Date: Monday, May 24, 2004
|
Click here to view MEDLINE citation |
|
More May, 2004 pharmacogenomics journal articles.- The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
by Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R.
Journal: Diabetes Care. 27(6):1394-8
- Communication of medical product risk: how effective is effective enough?
by Goldman SA.
Journal: Drug Saf. 27(8):519-34
- DNA microarrays as a tool in toxicogenomics.
by de Longueville F, Bertholet V, Remacle J.
Journal: Comb Chem High Throughput Screen. 7(3):207-11
- Mining the human genome for new health therapies.
by Zilberstein M.
Journal: Fertil Steril. 81 Suppl 2:4-8
- Pharmacogenomics and IBD: TPMT and thiopurines.
by Sandborn WJ.
Journal: Inflamm Bowel Dis. 10 Suppl 1:S35-7
- Pharmacogenetics in the treatment of breast cancer.
by Stearns V, Davidson NE, Flockhart DA.
Journal: Pharmacogenomics J. 4(3):143-53
- [Analysis and its application for prevention of side-effects of drugs and for evaluation of drug responsiveness]
by Inoue K.
Journal: Yakugaku Zasshi. 124(6):293-9
- Personalized medicine.
by Thrall JH.
Journal: Radiology. 231(3):613-6
- Allen D. Rose.
by Rose AD.
Journal: Nat Rev Drug Discov. 3(5):382
- Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.
by Aplenc R, Lange B.
Journal: Br J Haematol. 125(4):421-34
- How personalized medicine is changing the rules of drug life exclusivity.
by Sullivan CG.
Journal: Pharmacogenomics. 5(4):429-32
- Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients.
by Sparreboom A, Marsh S, Mathijssen RH, Verweij J, McLeod HL.
Journal: Invest New Drugs. 22(3):285-9
- [Cutaneous drug reactions: pharmacogenetic news]
by Buffard V, Roujeau JC.
Journal: Arch Pediatr. 11(5):489-92
- Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?
by Huang SM, Lesko LJ.
Journal: J Clin Pharmacol. 44(6):559-69
- Pharmacogenetics and bipolar disorder.
by Mamdani F, Groisman IJ, Alda M, Turecki G.
Journal: Pharmacogenomics J. 4(3):161-70
- Clinical relevance of advances in genetics and pharmacogenetics of IBD.
by Ahmad T, Tamboli CP, Jewell D, Colombel JF.
Journal: Gastroenterology. 126(6):1533-49
- Pharmacologic treatment of autism.
by Palermo MT, Curatolo P.
Journal: J Child Neurol. 19(3):155-64
- Variation in vaccine response in normal populations.
by Ovsyannikova IG, Jacobson RM, Poland GA.
Journal: Pharmacogenomics. 5(4):417-27
- Human genetics, environment, and communities of color: ethical and social implications.
by Sze J, Prakash S.
Journal: Environ Health Perspect. 112(6):740-5
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|